Streetbeat News

Analyst Ratings

MIRM

Analysts have provided bullish ratings for Mirum Pharmaceuticals (NASDAQ:MIRM) in the last quarter. The average price target is $72.0, implying an upside from the current price of $25.309. This represents a 4.95% decrease from the previous average price target of $75.75.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 3:00 pm

RNR

Over the past 3 months, 6 analysts have published their opinion on RenaissanceRe Holdings (NYSE:RNR) stock. The average 12-month price target for the stock is $242.0, a decrease of 0.17% from the previous average price target of $242.40.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 3:00 pm

VERX

Analysts have provided ratings for Vertex (NASDAQ:VERX) within the last quarter, with 1 bullish, 1 somewhat bullish, and 3 indifferent. The average price target is $23.6, implying an upside from the current price of $21.445. This average price target has increased by 4.1% over the past month.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 3:00 pm

AMR

APPF

ARCB

AZZ

CCOI

FLL

FMC

GAME

GOLF

LSXMA

MPW

MRUS

NSSC

OPTN

PODD

QSR

STRC

TCON

XPEV

Several companies have seen their ratings upgraded, downgraded, or initiated by various research firms. Upgrades include ArcBest Corp (ARCB), AppFolio Inc (APPF), Liberty SiriusXM Group (LSXMA), Insulet Corp (PODD), XPeng Inc (XPEV), Acushnet Holdings Corp (GOLF), and Cogent Communications Holdings Inc (CCOI). Downgrades include Full House Resorts Inc (FLL), Kanzhun Ltd (BZ), NAPCO Security Technologies Inc (NSSC), TRACON Pharmaceuticals Inc (TCON), Alpha Metallurgical Resources Inc (AMR), Medical Properties Trust Inc (MPW), Sarcos Technology & Robotics Corp (STRC), and Insulet Corp (PODD). Initiations include OptiNose Inc (OPTN), AZZ Inc (AZZ), Merus NV (MRUS), GameSquare Holdings Inc (GAME), Restaurant Brands International Inc (QSR), and FMC Corp (FMC).

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 3:00 pm

ADC

Agree Realty (NYSE:ADC) has received mostly bullish ratings from analysts in the last quarter, with 5 bullish, 3 somewhat bullish, and 1 indifferent rating. The average price target is $75.17, indicating potential upside from the current price of $61.09. However, this average has decreased by 2.76% from the previous average price target of $77.30.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 3:00 pm

IHS

Over the past 3 months, 4 analysts have published somewhat bullish opinions on IHS Holding (NYSE:IHS) stock, with an average price target of $15.75, implying an upside from the current price of $6.7064. This average has decreased by 26.74% from the previous average price target of $21.50.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 3:00 pm

BTCUSD

DOGEUSD

ETHUSD

SHIBUSD

XRPUSD

Crypto strategist Michaël van de Poppe suggests that the best time to invest in altcoins is eight to 10 months prior to the Bitcoin halving, a period known as 'Time Capitulation'. He highlighted that the Ethereum to Bitcoin pair reached its cycle low 252 days before Bitcoin's halving events. Despite current recession fears, van de Poppe remains optimistic about the strength of altcoins.

Portfolio Pulse from Murtuza Merchant

August 21, 2023 | 2:58 pm

CMPS

MNMD

PSIL

A recent study by the Federal Reserve indicates that cannabis and psychedelics consumption has reached all-time highs in 2022, particularly among adults aged 35-50. In other news, COMPASS Pathways (NASDAQ:CMPS) has entered into a securities purchase agreement for an initial $125 million and a potential additional $160 million, while MindMed (NASDAQ:MNMD) has secured a $50 million senior secured credit facility with K2 HealthVentures. The AdvisorShares Psychedelics ETF (NYSE:PSIL) opened at $1.8 on August 14, slightly below prior openings.

Portfolio Pulse from Lara Goldstein

August 21, 2023 | 2:55 pm

XPEV

JP Morgan analyst Nick Lai has maintained a Neutral rating on XPeng (NYSE:XPEV) and lowered the price target from $18 to $16.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:54 pm

UDR

JP Morgan analyst Anthony Paolone has maintained an Overweight rating on UDR (NYSE:UDR) but lowered the price target from $49 to $44.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 2:50 pm